Similar articles

• Conflicting evidence surrounding the clopidogrel and proton pump inhibitor drug interaction.

  Chua D, Shalansky SJ, Legal MG, Jung J. Chua D, et al. Arch Intern Med. 2010 Sep 13;170(16):1507-8; author reply 1508. doi: 10.1001/archinternmed.2010.299. Arch Intern Med. 2010. PMID: 20837843 No abstract available.
• Proton-pump inhibitors are associated with increased cardiovascular risk independent of clopidogrel use: a nationwide cohort study.

  Charlot M, Ahlehoff O, Norgaard ML, Jørgensen CH, Sørensen R, Abildstrøm SZ, Hansen PR, Madsen JK, Køber L, Torp-Pedersen C, Gislason G. Charlot M, et al. Ann Intern Med. 2010 Sep 21;153(6):378-86. doi: 10.7326/0003-4819-153-6-201009210-00005. Ann Intern Med. 2010. PMID: 20855802
• [Clopidogrel and proton pump inhibitors--boon or bane?].

  Labenz J, Meyners W, Petersen KU. Labenz J, et al. Dtsch Med Wochenschr. 2010 Feb;135(5):203-6. doi: 10.1055/s-0029-1244837. Epub 2010 Jan 26. Dtsch Med Wochenschr. 2010. PMID: 20104441 Review. German. No abstract available.
• Meta-analysis: the effects of proton pump inhibitors on cardiovascular events and mortality in patients receiving clopidogrel.

  Kwok CS, Loke YK. Kwok CS, et al. Aliment Pharmacol Ther. 2010 Apr;31(8):810-23. doi: 10.1111/j.1365-2036.2010.04247.x. Epub 2010 Jan 22. Aliment Pharmacol Ther. 2010. PMID: 20102352 Review.
• [Clopidogrel plus proton pump inhibitor: is infarct risk increased? (interview by Dr. Thomas Meissner)].

  Petersen KU. Petersen KU. MMW Fortschr Med. 2009 Jun 4;151(23):7. MMW Fortschr Med. 2009. PMID: 19591342 German. No abstract available.